糖尿病患者非糖尿病肾病的临床与组织学预测因素
该回顾性分析纳入2001-2024年49,075例接受肾活检的糖尿病患者,发现非糖尿病肾病(NDKD)总体检出率为58.8%,其中35.9%无合并糖尿病肾病(DN),22.9%为DN基础上的第二诊断。急性肾损伤和急性肾炎综合征与DN患者中NDKD诊断几率增加相关,且NDKD患者进展至终末期肾病的风险较单纯DN患者低2.56倍。
要点
- 糖尿病患者肾活检中NDKD检出率高达58.8%,其中22.9%为DN合并NDKD。
- 急性肾损伤和急性肾炎综合征提示DN患者中NDKD诊断几率增加。
- NDKD患者进展至终末期肾病的风险较单纯DN患者低2.56倍。
核心结论
- 糖尿病患者中NDKD患病率高,肾活检仍是糖尿病患者管理的关键工具。
研究设计与样本
- 回顾性分析2001-2024年49,075例接受肾活检的糖尿病患者临床与病理参数,并链接美国肾脏数据系统分析疾病进展。
主要发现
- NDKD总体检出率为58.8%,其中35.9%无合并DN,22.9%为DN基础上的第二诊断。
- 急性肾损伤和急性肾炎综合征与DN患者中NDKD诊断几率增加相关。
- 年龄小于30岁和60岁及以上患者NDKD患病率较高。
- 活检提示慢性化程度越高,NDKD诊断患病率越低。
- NDKD患者进展至终末期肾病的风险较单纯DN患者低2.56倍。
临床怎么用
- 对于糖尿病患者,尤其合并急性肾损伤或急性肾炎综合征时,应基于临床指征考虑肾活检以识别NDKD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The number of kidney biopsies performed in patients with diabetes has increased rapidly over the last two decades. However, the overall value of the biopsy has been questioned because any coexisting non-diabetic kidney disease (NDKD) is not identified in many patients. Here, we quantify the frequency of identifying NDKD and examine clinical indications, demographic factors, and histologic parameters that increase the odds of finding NDKD and the impact on developing end stage kidney disease. METHODS: A retrospective analysis of clinical and pathologic parameters of 49,075 biopsied patients with diabetes with and without diabetic nephropathy (DN) from 2001-2024 was performed. Data from the United States Renal Data Service were examined to determine the impact of a NDKD on disease progression to end stage kidney disease. RESULTS: NDKD was found in 58.8% of patients with diabetes who underwent kidney biopsy, including 35.9% without concurrent DN and 22.9% as a second diagnosis in DN. Acute kidney injury and acute nephritic syndrome had greater odds of a NDKD diagnosis in patients with DN. The youngest (under 30 years) and oldest (60 years and older) patients had a higher prevalence of NDKD. Higher chronicity on biopsy was associated with a lower prevalence of NDKD diagnosis. Patients with NDKD were 2.56-fold less likely to develop end stage kidney disease compared to patients with DN alone. CONCLUSIONS: This is the largest analysis examining prevalence of a NDKD in patients with diabetes and the impact of biopsy indication on finding a second diagnosis in biopsy-proven DN. The objective is to provide nephrologists with guidance in when to perform a biopsy based on the odds of finding a NDKD related to the patient's clinical indication. Given the high prevalence of NDKD, our study shows that kidney biopsy remains a critical tool in the care of diabetic patients.
引用
- Caza TN, Charu V, Dai DF, et al. Clinical and histologic predictors of non-diabetic kidney disease in patients with diabetes mellitus. Kidney Int. 2026. PMID: 42034202. doi:10.1016/j.kint.2026.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。